Revolutionizing Drug Discovery
MolecuLayer is a decentralized blockchain protocol built on Arbius, enabling a peer-to-peer marketplace for AI-driven drug discovery and biomolecular research with ESMFold v1.
Learn MoreVision
MolecuLayer, built on Arbius’s decentralized inference architecture, transforms drug discovery and biomolecular research by creating a peer-to-peer marketplace for AI-driven computational tasks like protein folding. Starting with Meta AI’s ESMFold v1, it operates as a DAO with model-specific tokens, addressing centralized platform limitations such as commercial use restrictions and high costs. With smart contracts for IP-NFT minting and crowd-funding, MolecuLayer ensures secure ownership and incentivizes complex tasks, powered by the MLYR token for governance, staking, and solver rewards.
Architecture
Solvers
GPU operators process protein folding prompts off-chain using ESMFold v1 on Arbius, storing results on IPFS and earning AIUS and MLYR rewards.
Researchers
Submit amino acid sequences to the MolecuLayer smart contract, deposit AIUS or other tokens, and receive IP-NFTs for result ownership.
Crowd-Funders
Contribute ERC-20 tokens or ETH to incentivize complex tasks, earning pro-rata IP-NFT shares for resulting data.
Tokenomics
The MLYR token, with a fixed supply of 5 million tokens, powers MolecuLayer’s governance, staking, and solver rewards, with 1.5 million emitted over ~7 years.
- Governance: MLYR holders vote on protocol upgrades and model integrations.
- Staking: Stakers earn AIUS from ESMFold v1 DAO and MLYR rewards.
- Solver Rewards: Solvers earn MLYR matching AIUS for completed tasks.
- veAIUS Incentives: 5% of MLYR incentivizes veAIUS voters to boost AIUS emissions to MolecuLayer models.
Token Distribution:
| Solver Rewards | 20% (1M MLYR) |
| Staking Rewards | 10% (500K MLYR) |
| Initial Liquidity | 10% (500K MLYR) |
| Liquidity Incentives | 5% (250K MLYR） |
| veAIUS Incentives | 5% (250K MLYR) |
| DAO | 10% (500K MLYR) |
| Team & Advisors | 20% (1M MLYR) |
| Investors | 20% (1M MLYR) |
IP-NFTs
MolecuLayer leverages IP-NFTs to secure on-chain ownership of computational results, inspired by Molecule Protocol. Upon task validation, smart contracts mint IP-NFTs embedding result metadata and legal agreements, ensuring transparent and transferable ownership. Crowd-funders receive pro-rata shares, democratizing IP rights for protein folding and biomolecular data.
Roadmap
Q3 2025: Testnet launch with ESMFold v1 DAO, IP-NFT minting, and MLYR rewards.
Q1 2026: Mainnet launch with crowd-funding and staking rewards.
Q3 2026: Add AlphaFold 2/3 derivatives and enhance governance.
Q1 2027: Expand to ligand docking and privacy-focused infrastructure.